Detalhe da pesquisa
1.
Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium.
Sci Rep
; 12(1): 21974, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539576
2.
Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy.
Cancer Res
; 82(19): 3532-3548, 2022 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950917
3.
A risk progression breast epithelial 3D culture model reveals Cx43/hsa_circ_0077755/miR-182 as a biomarker axis for heightened risk of breast cancer initiation.
Sci Rep
; 11(1): 2626, 2021 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33514777
4.
TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation.
Cancers (Basel)
; 12(9)2020 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32858904
5.
Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer.
Cancers (Basel)
; 12(2)2020 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32053966
6.
Adenosinergic Signaling Alters Natural Killer Cell Functional Responses.
Front Immunol
; 9: 2533, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425720